Microsize Signs Agreement to Acquire Micro-Macinazione from Lonza, Strengthening Leadership in Particle Size Control

Microsize, a leading CDMO specializing in particle size reduction and control technologies, today announced it has signed an agreement to acquire Micro-M...

November 25, 2025 | Tuesday | News
Kytopen and Excellos Partner to Explore Scalable Non-Viral Manufacturing for Next-Generation Cell Therapies

Collaboration will investigate how continuous flow cellular engineering and donor-to-dose manufacturing expertise may advance scalable, non-viral process...

November 13, 2025 | Thursday | News
Novartis Opens Carlsbad Radioligand Therapy Manufacturing Site as Part of $23B US Investment Plan

Carlsbad location is company’s third US-based radioligand therapy (RLT) manufacturing site New site expands manufacturing footprint to meet fut...

November 11, 2025 | Tuesday | News
Abzena and Mabqi Announce Strategic Partnership to Deliver End-to-End Antibody Discovery and Development

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, and Mabqi, a biotechnology company focused on the discovery and d...

November 07, 2025 | Friday | News
Argonaut Manufacturing Services Appoints Rick Hancock as CEO to Lead Next Phase of Growth

Argonaut Manufacturing Services, a leading contract development manufacturing organization (CDMO) specializing in aseptic drug product manufacturing...

November 05, 2025 | Wednesday | News
ChemDiv Expands Partnership to Advance Ratutrelvir, a Rationally Designed Ritonavir-Free Mpro Inhibitor for COVID-19

ChemDiv, a global provider of integrated drug discovery solutions,  announced the extension of its Chemistry, Manufacturing and Controls (CMC) servi...

October 31, 2025 | Friday | News
Codexis and Nitto Denko Avecia Partner to Evaluate ECO Synthesis® Platform for Next-Generation Oligonucleotide Manufacturing

Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, and Nitto Denko Avecia, In...

October 31, 2025 | Friday | News
Catalent Introduces New Corporate Brand to Champion “Missions That Matter” Across Global Healthcare

Reflects Catalent’s unparalleled service and best-in-class capabilities across the pharmaceutical, biotech and consumer health categories Rein...

October 29, 2025 | Wednesday | News
Lonza Accelerates the Future of Pharma QC with Acquisition of Redberry and Its Breakthrough Red One™ Rapid Microbiology Platform

  Lonza to acquire Redberry SAS, an innovative company specializing in rapid microbiology testing solutions Acquisition to include Red One&trade...

October 29, 2025 | Wednesday | News
Curia Completes $4 Million Upgrade of Valladolid API Suites to Meet Enhanced EU GMP Annex 1 Standards

Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of a $4 million investm...

October 28, 2025 | Tuesday | Regulatory
SK pharmteco Invests $6.1 Million to Expand U.S. Peptide Manufacturing Capabilities in California

SK pharmteco, a global contract development and manufacturing organization (CDMO), announced today a $6.1 million investment in its Rancho Cordova facili...

October 24, 2025 | Friday | News
Naobios and Tokyo Metropolitan Institute of Medical Science Partner to Develop Next-Generation Mpox Vaccine

Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of virus-ba...

October 24, 2025 | Friday | News
Abzena Grants Orion Exclusive License to CHAb™-Designed Antibody Targeting High-Unmet-Need Cancer

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, announced that Orion has obtained an exclusive focused commercial...

October 24, 2025 | Friday | News
Syngene Strengthens India’s Biologics Leadership with New GMP Bioconjugation Suite in Bengaluru

Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a GMP bioconjugation suite at its commerci...

October 23, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close